Literature DB >> 16724311

Stem cell transplantation for polycythemia vera.

Harald Reinhard1, Thomas Klingebiel, Peter Lang, Peter Bader, Dietrich Niethammer, Norbert Graf.   

Abstract

Polycythemia vera (PV) is a rare disease in children. A 9-year-old male was diagnosed following laboratory results acquired because of an acute appendicitis. Regular phlebotomy was performed for over 2 years followed by alpha-interferon treatment. At the age of 12 years, HLA-matched unrelated stem cell transplantation including T-cell depletion was done. The conditioning regimen consisted of busulfan, cyclophosphamide, and ATG. Chimerism was monitored during the whole post-transplant period. A single dose of donor T-lymphocytes was given at month 3. One year after transplantation, chimerism was complete. The patient is in complete remission and shows no signs of transplant-related morbidity at month 78. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 16724311     DOI: 10.1002/pbc.20906

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  4 in total

1.  Ruxolitinib treatment in an infant with JAK2+ polycythaemia vera-associated Budd-Chiari syndrome.

Authors:  Mehmet Enes Coskun; Sue Height; Anil Dhawan; Nedim Hadzic
Journal:  BMJ Case Rep       Date:  2017-07-14

2.  Myeloproliferative Neoplasms in Children.

Authors:  Inga Hofmann
Journal:  J Hematop       Date:  2015-08-02       Impact factor: 0.196

3.  Clinical and molecular characterisation of a prospectively collected cohort of children and adolescents with polycythemia vera.

Authors:  Holger Cario; Klaus Schwarz; Jan M Herter; Vladimir Komrska; Mary F McMullin; Milen Minkov; Charlotte Niemeyer; Dagmar Pospisilova; Harald Reinhard; Klaus-Michael Debatin; Heike L Pahl
Journal:  Br J Haematol       Date:  2008-06-28       Impact factor: 6.998

Review 4.  Clinical and hematological presentation of children and adolescents with polycythemia vera.

Authors:  Holger Cario; Mary Frances McMullin; Heike L Pahl
Journal:  Ann Hematol       Date:  2009-05-26       Impact factor: 3.673

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.